Publication Topic

Teta MJ, Wagner ME. 2009. Consistency and synergy. Blood 114(9):2000–2001 (author reply 2001).

Franzblau A, Hedgeman E, Jiang X, Chen Q, Hong B, Knutson K, Towey T, Adriaens P, Demond A, Gillespie B, Jolliet O, Lepkowski J, Garabrant D. The University of Michigan Dioxin Exposure Study: An Investigation of Serum Outliers for TEQ, 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF, and PCB-126. Dioxin 2009 Conference, Beijing, China. August 27, 2009.

Evans M, Fored CM, Bellocco R, Fitzmaurice G, Fryzek JP, McLaughlin JK, Nyrén O, Elinder CG. 2009. Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrol Dial Transplant 24(6):1908-1918.

Norgaard M, Jensen AO, Farkas DK, Pedersen L, Fryzek JP, Zhao S, Sorensen HT. Factors associated with Receipt of Splenectomy for Patients with Chronic Idiopathic Thrombocytopenic Purpura-A Nationwide Cohort Study. Pharmacoepidemiology and Drug Safety 18: S158-S159. August 1, 2009.

Franzblau A, Hedgeman E, Jiang X, Chen Q, Hong B, Knutson K, Towey T, Adriaens P, Demond A, Gillespie B, Jolliet O, Lepkowski J, Garabrant D. “The University of Michigan Dioxin Exposure Study: An investigation of serum outliers for TEQ, 2,3,7,8-TCDD, 2,3,4,7,8-PeCDF and PCB-126. Dioxin 2009 Conference, Beijing, China. August 1, 2009.

Schoonon WM, Li L, Fryzek JP, Kaye JA. Medical Contraindictions for Splenectomy among Adults with Immune Thrombocytopenic Purpura: Data from the General Practice Research Database 14th Annual Meeting of the European-Hematology- Association, Berlin, Germany. June 4-7, 2009.

Schoonen WM, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, Fryzek J, Kaye JA. 2009. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol 145(2):235-244.

Cherkowski G, Dietrich J, Chen F, Fryzek J, Bridges K. Heparin use and venous thromboembolism (VTE) among cancer patients receiving chemotherapy with a prior history of VTE. American Society of Clinical Oncology Annual Conference, Orlando, FL.May 29 – June 2, 2009.

Fryzek JP, Cetin K, Nørgaard M, Jensen AO, Jacobsen JB, Sørensen HT. The prognostic significance of bone metastases and skeletal-related events (SREs) in prostate cancer survival: a population-based historical cohort study in Denmark (1999-2007) American Society of Clinical Oncology Annual Conference, Orlando, FL. May 29 – June 2, 2009.

Barlev A, Yong M, Cherkowski G, Cetin K, Fryzek JP. Prevalence of early-stage prostate and estrogen receptor positive breast cancer patients receiving primary androgen deprivation therapy and aromatase inhibitors in the United States. American Society of Clinical Oncology Annual Conference, Orlando, FL. May 29 – June 2, 2009.